Syndecan-1 expression in laryngeal cancer

European Archives of Oto-Rhino-Laryngology

Volumn 259, Issue 3, 2002, Pages 115-118

  Klatka, Janusz ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b NONE   (Poland)

Author keywords

Laryngeal carcinoma; Syndecan 1

Indexed keywords

MONOCLONAL ANTIBODY; PARAFFIN; SYNDECAN 1;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MALE; OTORHINOLARYNGOLOGY; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROTEOGLYCANS; SYNDECAN-1; SYNDECANS;

EID: 0036202534     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-001-0429-7     Document Type: Article

References (29)

1. Syndecan-1 expression has prognostic significance in head and neck carcinoma
2. Syndecan-1 expression in diminished in acantholytic cutaneous squamous cell carcinoma
3. Biology of the syndecans: A family of trans-membrane heparan sulphate proteoglycans
4. Epidemiology of laryngeal cancer
5. Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence
6. Binding of human syndecan to extracellular matrix proteins
7. Pathologic and cytometric indicators of biologic behaviour in laryngeal cancer
8. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer
9. Reduced expression of cadherin/catenin complex in the transition from colorectal adenoma to carcinoma
10. Immunocytochemistry of cell surface heparan sulfate proteoglycan in mouse tissues. A light and electron microscopic study
11. Integrins, a family of cell surface receptors
12. The role of syndecan-1 in malignancies
13. Regulation of cell morphology and growth by syndecan-1
14. Immunohistochemical localization of syndecan in mouse skin tumors induced by UV irradiation; loss expression associated with malignant transformation
15. Syndecan in carcinomas produced from transformed epithelial cells in nude mice
16. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes
17. Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck
18. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix
19. Oro-facial neoplasms: Global epidemiology, risk factors and recommendations for research
20. Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-α
21. Clinical and morphological factors influencing the dynamics of the spread of laryngeal carcinoma in the patients from Lublin region in the years 1984-89
22. Expression of bcl-2 antigen in laryngeal carcinoma
23. Tumor angiogenesis in patients with laryngeal cancer
24. Expression of syndecan-1 inhibits cell invasion into type I collagen
25. Syndecan-1: A new prognostic marker in laryngeal cancer
26. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma
27. bFGF-syndecan complex at cell surface or immobilized to matrix proteins promotes cell growth
28. Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma
29. Cadherin cell adhesion receptors as a morphogenic regulator